drugset / Trial / NCT07216781

Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans

NCT07216781 ↗

Phase 1 Recruiting 24 enrolled Minicircle
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to investigate the safety and efficacy of a gene therapy for Klotho, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to understand the cognitive and health benefits of the Klotho gene therapy.

Timeline

Start
2025-10-06
Primary completion
2026-08
Completion
2026-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Klotho gene therapy Unknown — Subcutaneous

Indications

No indication recorded.